Skip to main content
. Author manuscript; available in PMC: 2019 May 14.
Published in final edited form as: Nature. 2018 Nov 7;563(7733):646–651. doi: 10.1038/s41586-018-0686-x

Extended Data Table 1:

Frequency of gRNAs in the human genome with denoted Cas9-mediated outcome precision.

inDelphi trained on Lib-A data from mESCs for 1-bp ins. module
inDelphi trained on Lib-A data from U2OS cells for 1-bp ins. module
Precision-X threshold (%) Precise product is a deletion (% of gRNAs) Precise product is a 1-bp insertion (% of gRNAs) Total % of gRNAs that are precise-X Precise product is a deletion (% of gRNAs) Precise product is a 1-bp insertion (% of gRNAs) Total % of gRNAs that are precise-X
10 82 38 93 70 78 97
15 61 23 75 44 64 87
20 43 15 55 27 53 72
25 30 10 39 17 44 58
30 21 6.6 28 11 36 46
35 15 4.4 19 6.9 28 34
40 10 2.9 13 4.1 21 25
45 6.5 1.9 8.4 2.4 15 18
50 4.3 1.3 5.6 1.4 10 12
55 2.8 0.8 3.6 0.8 6.7 7.5
60 1.8 0.5 2.3 0.5 4.0 4.4
65 1.1 0.3 1.5 0.2 2.2 2.4
70 0.7 0.2 0.9 0.1 1.1 1.2
75 0.4 0.1 0.5 0.04 0.5 0.5
80 0.2 0.08 0.3 0.01 0.2 0.2
85 0.08 0.04 0.1 0.003 0.07 0.08
90 0.03 0.02 0.05 0.0007 0.03 0.03

SpCas9 gRNAs in human exons and introns in mESCs (n = 1,003,524 SpCas9 gRNAs) and U2OS cells (n = 4,498,780 SpCas9 gRNAs). Predictions were smoothed with Gaussian noise (Supplementary Methods).